Post a Free Blog

Submit A Press Release

Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Filter by Categories
Action
Animation
ATP Tour (ATP)
Auto Racing
Baseball
Basketball
Boxing
Breaking News
Business
Business
Business Newsletter
Call of Duty (CALLOFDUTY)
Canadian Football League (CFL)
Car
Celebrity
Champions Tour (CHAMP)
Comedy
CONCACAF
Counter Strike Global Offensive (CSGO)
Crime
Dark Comedy
Defense of the Ancients (DOTA)
Documentary and Foreign
Drama
eSports
European Tour (EPGA)
Fashion
FIFA
FIFA Women’s World Cup (WWC)
FIFA World Cup (FIFA)
Fighting
Football
Formula 1 (F1)
Fortnite
Golf
Health
Hockey
Horror
IndyCar Series (INDY)
International Friendly (FRIENDLY)
Kids & Family
League of Legends (LOL)
LPGA
Madden
Major League Baseball (MLB)
Mixed Martial Arts (MMA)
MLS
Movie and Music
Movie Trailers
Music
Mystery
NASCAR Cup Series (NAS)
National Basketball Association (NBA)
National Football League (NFL)
National Hockey League (NHL)
National Women's Soccer (NWSL)
NBA Development League (NBAGL)
NBA2K
NCAA Baseball (NCAABBL)
NCAA Basketball (NCAAB)
NCAA Football (NCAAF)
NCAA Hockey (NCAAH)
Olympic Mens (OLYHKYM)
Other
Other Sports
Overwatch
PGA
Politics
Premier League (PREM)
Romance
Sci-Fi
Science
Soccer
Sports
Sports
Technology
Tennis
Thriller
Truck Series (TRUCK)
True Crime
Ultimate Fighting Championship (UFC)
Uncategorized
US
Valorant
Western
Women’s National Basketball Association (WNBA)
Women’s NCAA Basketball (WNCAAB)
World
World Cup Qualifier (WORLDCUP)
WTA Tour (WTA)
Xfinity (XFT)
XFL
0
-- Advertisement --spot_img
HomeBusinessSINT Earnings. Should you Buy?

SINT Earnings. Should you Buy?

Add to Favorite
Added to Favorite
Credit Twitter

 

SINTX Technologies, Inc. (NASDAQ: SINT) , an original equipment manufacturer (OEM) of silicon nitride ceramic for medical and non-medical applications, announced today the filing of its 10-K for the year ended December 31, 2020.

2020 represented SINTX’s second full year as an advanced materials company. As COVID-19 spread and negatively impacted multiple potential opportunities, the Company was able to quickly and successfully adjust its 2020 strategic plan and capitalize on the discovery that its silicon nitride rapidly inactivates the SARS-CoV-2 virus. SINTX aggressively invested in key personnel, new collaborations with university and government laboratories, and new capital equipment. SINTX was able to engage with new partners and begin supporting their development of new antipathogenic products across a wide range of applications. SINTX is now leveraging the foundational successes of 2020 and is excited about its future. 2021 represents SINTX’s 25th  year in business.

SINTX plans to host a conference call to provide an update on the business. The call is scheduled for Tuesday, March 30, 2021 at 1:30 p.m. ET. The call can be accessed through dial-in: Toll-free 877-524-8416; International 412-902-1028. For those who are not available to listen to the call, a digital replay will be archived on the News & Media section of the SINTX website under Presentations.

Questions will not be taken during the call. Investors and interested parties may submit questions prior to the call via email to  IR@SINTX.com. Questions will be accepted through 9:00 a.m. ET, on Thursday, March 22, 2021.

About Sintx
SINTX Technologies is an OEM ceramics company that develops and commercializes silicon nitride for medical and non-medical applications. The core strength of SINTX Technologies is the manufacturing, research, and development of silicon nitride ceramics for external partners. The Company presently manufactures silicon nitride powders and components in its FDA registered, ISO 9001:2015 certified, ISO 13485:2016 certified, and AS9100D certified manufacturing facility.

CWEB Analyst see the stock as a caution bearish indicator ahead due filing report of the new 10K.   It looks like they only have money for one year according to the 10-K.   It will be a turbulent ride.

Subscribe to get Latest News Updates

Latest News

You may like more
more

Sally Beauty Holdings, Inc. (SBH) Earnings Report Highlights

Earnings per share of $0.4562, slightly below the estimated...

Alibaba Group Holding Limited (NYSE:BABA): A Comprehensive Analysis

The consensus price target for Alibaba's stock has fluctuated...

TriSalus Life Sciences, Inc. (NASDAQ: TLSI) Earnings Report Highlights

TriSalus Life Sciences, Inc. (NASDAQ:TLSI) reported an actual EPS...

Flywire Corporation’s Financial Performance and Competitive Analysis

Flywire Corporation (NASDAQ:FLYW) is not generating returns above its...